| Dr Anthony Massimillo, MD | |
|
300 Old Country Rd Ste 31, Mineola, NY 11501-4112 | |
| (516) 294-9380 | |
| (516) 294-5351 |
| Full Name | Dr Anthony Massimillo |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 39 Years |
| Location | 300 Old Country Rd Ste 31, Mineola, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043277692 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 169701 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").
The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
In a study that could lead to wide use of inexpensive ultrasound screenings for osteoporosis, researchers found data from ultrasonography of the calcaneus was equal to data gathered using dual-energy x-ray absorptiometry, which is considered the gold standard for assessing bone health.
A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population.
› Verified 1 days ago
| Entity Name | Long Island Gastroenterology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538104377 PECOS PAC ID: 9234028978 Enrollment ID: O20060215000006 |
News Archive
Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").
The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
In a study that could lead to wide use of inexpensive ultrasound screenings for osteoporosis, researchers found data from ultrasonography of the calcaneus was equal to data gathered using dual-energy x-ray absorptiometry, which is considered the gold standard for assessing bone health.
A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population.
› Verified 1 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").
The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
In a study that could lead to wide use of inexpensive ultrasound screenings for osteoporosis, researchers found data from ultrasonography of the calcaneus was equal to data gathered using dual-energy x-ray absorptiometry, which is considered the gold standard for assessing bone health.
A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Massimillo, MD 300 Old Country Rd Ste 31, Mineola, NY 11501-4112 Ph: (516) 294-9380 | Dr Anthony Massimillo, MD 300 Old Country Rd Ste 31, Mineola, NY 11501-4112 Ph: (516) 294-9380 |
News Archive
Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").
The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
In a study that could lead to wide use of inexpensive ultrasound screenings for osteoporosis, researchers found data from ultrasonography of the calcaneus was equal to data gathered using dual-energy x-ray absorptiometry, which is considered the gold standard for assessing bone health.
A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population.
› Verified 1 days ago
Dr. Marlene Martins Lobato, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 173 Mineola Blvd, Suite 403, Mineola, NY 11501 Phone: 516-741-8891 Fax: 516-741-8829 | |
Michael Garrison, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 200 Old Country Rd, Suite 450, Mineola, NY 11501 Phone: 516-663-9500 Fax: 516-663-4613 | |
Dr. Anupama Ananda, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 190 Willis Ave, Suite 210, Mineola, NY 11501 Phone: 516-739-7290 Fax: 516-793-7291 | |
Mr. Jeffrey Liu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 297 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-1377 Fax: 516-294-5574 | |
Dr. Jonathan Shulman, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2381 | |
John I Hogan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N Ste 432, Mineola, NY 11501 Phone: 516-663-2507 |